Publications found:
272
Sort by:
Anticoagulants Market Report by Drug Class (Novel Oral Anticoagulants (NOACs), Heparin and Low Molecular Weight Heparin (LMWH), Vitamin K Antagonist, and Others), Route of Administration (Oral Anticoagulant, Injectable Anticoagulant), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores, and Others), Application (Atrial Fibrillation and Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Others), and Region 2026-2034
US$ 3,999.00
The global anticoagulants market size reached USD 48.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 97.7 Billion by 2034, exhibiting a growth rate (CAGR) of 7.80% duri...
June 2026
148 pages
Clot Buster Drugs Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Type (Fibrin Specific Drugs {Tissue Plasminogen Activator, Reteplase, Tenecteplase, Others} v/s Non-Fibrin Specific Drugs {Urokinase, Streptokinase, Plasminogen Activating Complex}), By Application (Myocardial Infarction, Pulmonary Embolism, Deep Vein Thrombosis, Acute Ischemic Strokes, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Clot Buster Drugs Market is projected to experience robust growth, expanding from a valuation of USD 35.72 Billion in 2025 to USD 55.78 Billion by 2031, reflecting a compound annual growth...
May 2026
185 pages
Atrial Fibrillation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Pharmacological Treatment (Anti-arrhythmic Drugs), Non-Pharmacological Treatment(Catheter Ablation, Maze Surgery, Electric Cardioversion), By End-use (Hospital, Specialty Clinics, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Atrial Fibrillation Market is poised for significant growth, projected to expand from USD 22.61 Billion in 2025 to USD 35.34 Billion by 2031, achieving a CAGR of 7.73%. This market encompas...
May 2026
185 pages
Lipid Regulators Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type {Statins (Branded statins, Statin combinations, and Generic statins), and Non-statins (Fibric-acid derivatives, Bile-acid Sequestrants, Nicotinic Acid Derivatives, and Other New Products)}, By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Lipid Regulators Market is projected to expand from USD 7.89 Billion in 2025 to USD 11.14 Billion by 2031, reflecting a compound annual growth rate of 5.92%. Lipid regulators function as ph...
May 2026
180 pages
Hypercholesterolemia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Genetic Hypercholesterolemia, Acquired Hypercholesterolemia), By Treatment Type (Statins, PCSK9 Inhibitors, Ezetimibe, Bile Acid Sequestrants, Niacin, Bempedoic Acid, Others), By End User (Hospitals, Specialty Cardiac Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Hypercholesterolemia Treatment Market is projected to expand significantly, rising from USD 21.13 Million in 2025 to USD 33.51 Million by 2031, demonstrating a robust 7.99% CAGR. This growt...
May 2026
182 pages
Wolff Parkinson white syndrome Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Type A, Type B), By Diagnosis (Electrocardiogram (ECG), Electrophysiological Testing, Other Diagnosis), By Treatment (Drugs, Cardioversion, Radiofrequency Catheter Ablation, Surgery, Artificial Pacemaker, Other Treatments), By End User (Hospitals And Clinics, Academic and Research Institutes, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Wolff Parkinson White syndrome Market is projected to expand from USD 1.62 Billion in 2025 to USD 2.28 Billion by 2031, registering a CAGR of 5.86%. Wolff-Parkinson-White (WPW) syndrome, a...
May 2026
185 pages
Amlodipine Besylate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Hypertension, Chronic Stable Angina, Vasospastic Angina, Coronary Artery Disease, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global Amlodipine Besylate market is projected to expand from USD 470.57 million in 2025 to USD 618.81 million by 2031, demonstrating a compound annual growth rate (CAGR) of 4.67%. Amlodipine Besy...
May 2026
182 pages
Homozygous Familial Hypercholesterolemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Statins, Cholesterol Absorption Inhibitors, PCSK9 Inhibitors, MTP Inhibitors, ANGPTL3 Inhibitors), By Route of Administration (Oral, Parenteral, Nasal), By Technology (CRISPR-Cas9, RNA Interference, Nanoparticle-Based Therapies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Homozygous Familial Hypercholesterolemia (HoFH) Market is projected to expand from USD 94.78 Million in 2025 to USD 111.01 Million by 2031, demonstrating a Compound Annual Growth Rate (CAGR...
May 2026
185 pages
Metoprolol Succinate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Hypertension, Chronic Heart Failure, Angina Pectoris, Arrhythmias, Anxiety, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for Metoprolol Succinate, a beta1-selective adrenoceptor blocker used to manage hypertension, angina pectoris, and chronic heart failure by regulating heart rate and cardiac output,...
May 2026
185 pages
Simvastatin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Hyperlipidemia, Coronary Heart Disease, Diabetes-Related Dyslipidemia, Stroke, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Simvastatin Market is projected to grow from USD 150.19 Million in 2025 to USD 237.14 Million by 2031, achieving a 7.91% CAGR. Simvastatin, a widely prescribed HMG-CoA reductase inhibitor,...
May 2026
177 pages
Takotsubo Syndrome Therapeutic Market Forecasts to 2034 – Global Analysis By Product Type (Anticoagulants, Beta-Blockers, Aldosterone Receptor Blockers, Statins, Diuretics, Angiotensin-Converting Enzyme (ACE) Inhibitors, Dual Antiplatelet Therapy (DAPT) and Other Product Types), Diagnosis, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Takotsubo Syndrome Therapeutic Market is accounted for $0.52 billion in 2026 and is expected to reach $0.99 billion by 2034 growing at a CAGR of 8.3% during th...
May 2026
200 pages
Global Anti-ANGPTL3 Antibody Drugs Market Growth 2026-2032
US$ 3,660.00
The global Anti-ANGPTL3 Antibody Drugs market size is predicted to grow from US$ 145 million in 2025 to US$ 295 million in 2032; it is expected to grow at a CAGR of 10.0% from 2026 to 2032. In 2025, g...
May 2026
84 pages
Losartan Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source (Contract Manufacturing Organizations, In-House), By Application (Hypertension, Stroke, Diabetic Nephropathy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Losartan market is anticipated to expand from USD 743.21 million in 2025 to USD 933.37 million by 2031, reflecting a compound annual growth rate (CAGR) of 3.87%. As an angiotensin II recept...
May 2026
185 pages
Global Cardiac Myosin Inhibitors Market Growth 2026-2032
US$ 3,660.00
The global Cardiac Myosin Inhibitors market size is predicted to grow from US$ 815 million in 2025 to US$ 1770 million in 2032; it is expected to grow at a CAGR of 12.0% from 2026 to 2032. In 2025, gl...
April 2026
85 pages
Global Myosin Inhibitors Market Growth 2026-2032
US$ 3,660.00
The global Myosin Inhibitors market size is predicted to grow from US$ 908 million in 2025 to US$ 2058 million in 2032; it is expected to grow at a CAGR of 12.8% from 2026 to 2032. In 2025, global Myo...
April 2026
85 pages
Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2026-2034
US$ 3,999.00
The global congestive heart failure drugs market size reached USD 10.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 25.6 Billion by 2034, exhibiting a growth rate (CAG...
April 2026
150 pages
Hypercholesterolemia Market Size by Type (Type 1, Type 2A, Type 2B, Type 3, Type 4, Type 5, and Others), Diagnosis and Treatment (Diagnosis, Treatment), Patient (Pediatric, Adults, Geriatric), End User (Hospitals, Specialty Clinics, Home Healthcare, and Others), and Region ?2026-2034?
US$ 3,999.00
The global hypercholesterolemia market size reached USD 22.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 65.0 Billion by 2034, exhibiting a growth rate (CAGR) of 12.0...
April 2026
136 pages
Atrial Fibrillation Treatment Market Report by Disorder Type (Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Permanent Atrial Fibrillation, and Others), Treatment Type (Medical Procedures, Medication), End-User (Hospitals, Cardiac Labs, Ambulatory Surgical Centers, and Others), and Region 2026-2034
US$ 3,999.00
The global atrial fibrillation treatment market size reached USD 9.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 21.2 Billion by 2034, exhibiting a growth rate (CAGR)...
April 2026
139 pages
Stroke Management Market Report by Type (Diagnostics, Therapeutics), Application (Ischemic Stroke, Haemorrhagic Stroke, and Others), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others), and Region 2026-2034
US$ 3,999.00
The global stroke management market size reached USD 40.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 65.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.60% d...
April 2026
140 pages
Hypertrophic Cardiomyopathy Therapeutics Market Size, Share & Trends Analysis Report By Drug Class, (Beta Blockers, Calcium Channel Blockers), By Disease Type, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global hypertrophic cardiomyopathy therapeutics market size was estimated at USD 1.43 billion in 2025 and is projected to reach USD 2.16 billion by 2033, growing at a CAGR of 5.5% from 2026 to 203...
March 2026
150 pages
Global Warfarin Sodium Tablets Market Growth 2026-2032
US$ 3,660.00
The global Warfarin Sodium Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Warfarin is an oral anticoa...
March 2026
82 pages
Global Doxazosin Mesylate Tablets Market Growth 2026-2032
US$ 3,660.00
The global Doxazosin Mesylate Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Doxazosin is commonly us...
March 2026
105 pages
